(Q85179320)

English

Immunogenicity and protective efficacy of a DNA vaccine encoding a chimeric protein of avian influenza hemagglutinin subtype H5 fused to CD154 (CD40L) in Pekin ducks

scientific article published on 30 October 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937323%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Immunogenicity and protective efficacy of a DNA vaccine encoding a chimeric protein of avian influenza hemagglutinin subtype H5 fused to CD154 (CD40L) in Pekin ducks (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937323%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

avian influenza

1 reference

based on heuristic

inferred from title

author name string

Qingxia Yao

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937323%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Karl P Fischer

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937323%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Lena Li

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937323%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Babita Agrawal

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937323%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Yohannes Berhane

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937323%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

D Lorne Tyrrell

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937323%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Klaus S Gutfreund

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937323%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

John Pasick

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937323%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

publication date

30 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937323%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937323%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937323%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

51

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937323%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

8147-8156

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937323%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Global patterns of influenza a virus in wild birds

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Influenza A viruses of migrating wild aquatic birds in North America.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Characterization of a highly pathogenic H5N1 avian influenza A virus isolated from duck meat.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Pathogenicity of H5 influenza viruses for ducks

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

A conventional, inactivated oil emulsion vaccine suppresses shedding and prevents viral meat colonisation in commercial (Pekin) ducks challenged with HPAI H5N1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Domestic ducks and H5N1 influenza epidemic, Thailand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Free-grazing ducks and highly pathogenic avian influenza, Thailand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Highly pathogenic avian influenza (H5N1) in the commercial domestic ducks of South Korea

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Strategies and challenges for eliciting immunity against avian influenza virus in birds.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Transmission of highly pathogenic avian influenza H5N1 virus in Pekin ducks is significantly reduced by a genetically distant H5N2 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Pathogenicity and vaccine efficacy of different clades of Asian H5N1 avian influenza A viruses in domestic ducks.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Effect of vaccination on transmission of HPAI H5N1: the effect of a single vaccination dose on transmission of highly pathogenic avian influenza H5N1 in Peking ducks

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Principles for vaccine protection in chickens and domestic waterfowl against avian influenza: emphasis on Asian H5N1 high pathogenicity avian influenza.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Field study on the use of inactivated H5N2 vaccine in avian species

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Field assessment of an H5N1 inactivated vaccine in chickens and ducks in Lao PDR

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Efficacy of inactivated vaccines against H5N1 avian influenza infection in ducks

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Achievement of avian influenza virus-like particles that could be used as a subunit vaccine against low-pathogenic avian influenza strains in ducks

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Assessment of the protection afforded by triple baculovirus recombinant coexpressing H5, N3, M1 proteins against a homologous H5N3 low-pathogenicity avian influenza virus challenge in Muscovy ducks

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Efficacy of an inactivated and a fowlpox-vectored vaccine in Muscovy ducks against an Asian H5N1 highly pathogenic avian influenza viral challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Prime-boost vaccination with a fowlpox vector and an inactivated avian influenza vaccine is highly immunogenic in Pekin ducks challenged with Asian H5N1 HPAI.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Immunologic responses to West Nile virus in vaccinated and clinically affected horses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Efficacy of an infectious hematopoietic necrosis (IHN) virus DNA vaccine in Chinook Oncorhynchus tshawytscha and sockeye O. nerka salmon

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Plasmid-mediated growth hormone-releasing hormone efficacy in reducing disease associated with Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Epidermal DNA vaccine for influenza is immunogenic in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Priming with a DNA vaccine delivered by attenuated Salmonella typhimurium and boosting with a killed vaccine confers protection of chickens against infection with the H9 subtype of avian influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

DNA vaccines: ready for prime time?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

The TNF and TNF receptor superfamilies: integrating mammalian biology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

The molecular architecture of the TNF superfamily

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

TNF/TNFR family members in costimulation of T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Molecular mechanism and function of CD40/CD40L engagement in the immune system.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

The CD40 antigen and its ligand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Recent advances on the role of CD40 and dendritic cells in immunity and tolerance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

CD40:CD40L interactions in X-linked and non-X-linked hyper-IgM syndromes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Help for cytotoxic-T-cell responses is mediated by CD40 signalling

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

CD40 AND CD154 IN CELL-MEDIATED IMMUNITY

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

CD40-CD40 ligand interaction between dendritic cells and CD8+ T cells is needed to stimulate maximal T cell responses in the absence of CD4+ T cell help

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Humoral immune responses in CD40 ligand-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

The role of CD40 and CD154/CD40L in dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Improved immunogenicity of a self tumor antigen by covalent linkage to CD40 ligand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Modulation of immune responses to bovine herpesvirus-1 in cattle by immunization with a DNA vaccine encoding glycoprotein D as a fusion protein with bovine CD154.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

A dual-function DNA vaccine encoding carcinoembryonic antigen and CD40 ligand trimer induces T cell-mediated protective immunity against colon cancer in carcinoembryonic antigen-transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Multimeric soluble CD40 ligand (sCD40L) efficiently enhances HIV specific cellular immune responses during DNA prime and boost with attenuated poxvirus vectors MVA and NYVAC expressing HIV antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Targeting with bovine CD154 enhances humoral immune responses induced by a DNA vaccine in sheep

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Identification and characterization of functional CD154 (CD40 ligand) in the Pekin duck

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Immunotargeting with CD154 (CD40 ligand) enhances DNA vaccine responses in ducks

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Wild bird influenza survey, Canada, 2005

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Vaccination of chickens with recombinant Salmonella expressing M2e and CD154 epitopes increases protection and decreases viral shedding after low pathogenic avian influenza challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

The immunogenicity and efficacy against H5N1 challenge of reverse genetics-derived H5N3 influenza vaccine in ducks and chickens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Are ducks contributing to the endemicity of highly pathogenic H5N1 influenza virus in Asia?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Reemerging H5N1 influenza viruses in Hong Kong in 2002 are highly pathogenic to ducks

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Vaccines protect chickens against H5 highly pathogenic avian influenza in the face of genetic changes in field viruses over multiple years

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Susceptibility of Canada Geese (Branta canadensis) to highly pathogenic avian influenza virus (H5N1)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Efficacy of a commercial inactivated H5 influenza vaccine against highly pathogenic avian influenza H5N1 in waterfowl evaluated under field conditions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2010.09.081

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937323%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937323%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q85179320&oldid=1933724582"